SELAS PHARMACIE MARTIN-PRIVAT : revenue, balance sheet and financial ratios

SELAS PHARMACIE MARTIN-PRIVAT is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTPELLIER (34070), this company of category PME shows in 2023 a revenue of 3.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE MARTIN-PRIVAT (SIREN 847800430)
Indicator 2024 2023 2022 2021
Revenue N/C 3 456 302 € 2 783 745 € 2 589 878 €
Net income 266 834 € 613 480 € 465 566 € 496 208 €
EBITDA N/C 848 664 € 659 663 € 716 360 €
Net margin N/C 17.7% 16.7% 19.2%

Revenue and income statement

In 2024, SELAS PHARMACIE MARTIN-PRIVAT generates positive net income of 267 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2024: 496 k€ -> 267 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

266 834 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 83%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

83.202%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

50.452%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

45.7%

Solvency indicators evolution
SELAS PHARMACIE MARTIN-PRIVAT

Sector positioning

Debt ratio
83.2 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average

In 2024, the debt ratio of SELAS PHARMACIE MARTIN-PR... (83.20) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
50.45% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +7 pts over 3 years

In 2024, the financial autonomy of SELAS PHARMACIE MARTIN-PR... (50.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
2.15 years 2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good -10 pts over 2 years

In 2023, the repayment capacity of SELAS PHARMACIE MARTIN-PR... (2.15) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 316.58. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

316.579

Liquidity indicators evolution
SELAS PHARMACIE MARTIN-PRIVAT

Sector positioning

Liquidity ratio
316.58 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent

In 2024, the liquidity ratio of SELAS PHARMACIE MARTIN-PR... (316.58) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
1.55x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average -9 pts over 2 years

In 2023, the interest coverage of SELAS PHARMACIE MARTIN-PR... (1.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE MARTIN-PRIVAT

Positioning of SELAS PHARMACIE MARTIN-PRIVAT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE MARTIN-PRIVAT is estimated at 3 725 199 € (range 2 594 170€ - 5 573 112€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2594k€ 3725k€ 5573k€
3 725 199 € Range: 2 594 170€ - 5 573 112€
NAF 5 année 2024

Valuation method used

Net Income Multiple
266 834 € × 14.0x = 3 725 200 €
Range: 2 594 170€ - 5 573 112€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE MARTIN-PRIVAT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE MARTIN-PRIVAT

What is the revenue of SELAS PHARMACIE MARTIN-PRIVAT ?

The revenue of SELAS PHARMACIE MARTIN-PRIVAT in 2023 is 3.5 M€.

Is SELAS PHARMACIE MARTIN-PRIVAT profitable?

Yes, SELAS PHARMACIE MARTIN-PRIVAT generated a net profit of 267 k€ in 2024.

Where is the headquarters of SELAS PHARMACIE MARTIN-PRIVAT ?

The headquarters of SELAS PHARMACIE MARTIN-PRIVAT is located in MONTPELLIER (34070), in the department Herault.

Where to find the tax return of SELAS PHARMACIE MARTIN-PRIVAT ?

The tax return of SELAS PHARMACIE MARTIN-PRIVAT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE MARTIN-PRIVAT operate?

SELAS PHARMACIE MARTIN-PRIVAT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.